Intracellular organization of insulin signaling and GLUT4 translocation.
Level 5 - mechanism / opinion, no new human data
Narrative review of cellular and molecular mechanisms without original human data or systematic search methods.
PubMed 11237212 · doi:10.1210/rp.56.1.175
What was done
This narrative review synthesizes the physiological functions and tissue distributions of facilitative glucose transporters (GLUT1–4, GLUTX1, and GLUT5). It examines the intracellular signaling cascades and vesicle trafficking components responsible for insulin-stimulated GLUT4 translocation and recycling, primarily in adipocytes.
What was found
The abstract reports no numerical findings or statistical measures. It details the specialized distribution of glucose transporters: GLUT1 in human erythrocytes and blood-brain barrier endothelium; GLUT3 in neurons; GLUT2 as a low-affinity sensor/transporter in liver, intestine, kidney, and pancreatic beta cells; and GLUTX1 in early blastocyst development. It characterizes GLUT4 as the primary insulin-responsive transporter in muscle and adipose tissue that remains sequestered internally under basal conditions, translocates to the plasma membrane in response to elevated insulin, and returns to intracellular storage via endocytosis when insulin declines.
Why it matters
Understanding the cellular mechanisms regulating GLUT4 sequestration and translocation outlines how target tissues handle glucose clearance and identifies potential molecular vulnerabilities leading to peripheral insulin resistance and diabetes.
Limits
This is a narrative review with no systematic literature search or original empirical data. The abstract provides no quantitative metrics or human clinical data, and the molecular pathways described focus predominantly on adipocytes rather than the full range of insulin-responsive tissues.
Cited by
- supports Most glucose uptake into the brain does not require insulin, whereas glucose uptake into skeletal muscle is insulin-dependent.